G. Schellong
- Hematology top 5%
- Acute Myeloid Leukemia Research 9
- Hematopoietic Stem Cell Transplantation 3
-
- Acute Lymphoblastic Leukemia research 12
-
- Childhood Cancer Survivors' Quality of Life 3
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 6
-
- Neutropenia and Cancer Infections 5
-
- Ovarian cancer diagnosis and treatment 3
-
- Lung Cancer Treatments and Mutations 3
G. Schellong
30 papers receiving 644 citations
Peers
Comparison fields: 5 of 59
- Hematology 260
- Public Health, Environmental and Occupational Health 448
- Pediatrics, Perinatology and Child Health 277
- Pathology and Forensic Medicine 117
- Genetics 55
Countries citing papers authored by G. Schellong
This map shows the geographic impact of G. Schellong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schellong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schellong more than expected).
Fields of papers citing papers by G. Schellong
This network shows the impact of papers produced by G. Schellong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schellong. The network helps show where G. Schellong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Schellong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 20 | |
| 2 | 1998 | 34 | |
| 3 | 1997 | 56 | |
| 4 | 1990 | 21 | |
| 5 | 1990 | 86 | |
| 6 | 1990 | 125 | |
| 7 | 1989 | 9 | |
| 8 | 1987 | 5 | |
| 9 | 1987 | 72 | |
| 10 | 1987 | 1 | |
| 11 | 1986 | 8 | |
| 12 | 1985 | 3 | |
| 13 | 1985 | 1 | |
| 14 | 1985 | 1 | |
| 15 | 1983 | 3 | |
| 16 | 1981 | 53 | |
| 17 | 1981 | 67 | |
| 18 | [Prognosis improvements in children with acute myelocytic leucemia after more intensive induction therapy (author's transl)]. | 1979 | 9 |
| 19 | [Concordant leukemia in identical twins (author's transl)]. | 1979 | 1 |
| 20 | 1953 | 2 |
About G. Schellong
G. Schellong is a scholar working on Hematology, Reproductive Medicine, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 31 papers that have together received 676 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (12 papers), Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (6 papers), Neutropenia and Cancer Infections (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Hematology (260 citations), Public Health, Environmental and Occupational Health (448 citations), Pediatrics, Perinatology and Child Health (277 citations), Pathology and Forensic Medicine (117 citations) and Genetics (55 citations). G. Schellong has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include G. Henze, H. Riehm, Helmut Gadner, H. Langermann, F. Lampert, Jürgen Brämswig, J. Ritter, B. Kornhuber, D. Niethammer and Alfred Reiter. Their work appears in journals such as European Journal of Endocrinology, Cancer, The Journal of Pediatrics, International Journal of Radiation Oncology*Biology*Physics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.